Concise CCO activity on selecting second-generation antipsychotics for treatment augmentation in patients with MDD and managing adverse events
Free slides from CCO and Rakesh Jain, MD, MPH: Expert insights on efficacy, role of antipsychotics in MDD, mitigating and manage adverse events
Free slides from CCO and Christoph U. Correll, MD: Expert insights on comorbidities in treatment augmentation for MDD
Expert commentary on prevention and emerging treatment strategies for the COVID-19 pandemic from CCO
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.